Levoglucosan is a major product of biomass pyrolysis. While this pyrolyzed biomass, also known as bio-oil, contains sugars that are an attractive fermentation substrate, commonlyused biocatalysts, such as Escherichia coli, lack the ability to metabolize this anhydrosugar. It has previously been shown that recombinant expression of the levoglucosan kinase enzyme enables use of levoglucosan as carbon and energy source. Here, ethanologenic E. coli KO11 was engineered for levoglucosan utilization by recombinant expression of levoglucosan kinase from Lipomyces starkeyi. Our engineering strategy uses a codon-optimized gene that has been chromosomally integrated within the pyruvate to ethanol (PET) operon and does not require additional antibiotics or inducers. Not only does this engineered strain use levoglucosan as sole carbon source, but it also ferments levoglucosan to ethanol. This work demonstrates that existing biocatalysts can be easily modified for levoglucosan utilization.
INTRODUCTION
While enormous progress has been made in engineering biocatalysts to produce a variety of biorenewable fuels and chemicals from pure sugars (Clomburg and Gonzalez, 2010) , the economically viable use of biomass-derived sugars is still a challenge. Hydrolysis of biomass to release fermentable sugars has been the focus of intense research; an alternative method of extracting sugars from biomass is thermochemical processing, in which biomass is subjected to rapid thermal decomposition by fast pyrolysis to yield syngas, bio-oil and bio-char (Brown, 2007) . A recent comparative cost analysis showed fast pyrolysis to be an attractive means of biofuels production relative to both enzymatic hydrolysis and gasification (Anex, 2010) .
Bio-oil is a fluid that contains up to 20% water and a mixture of anhydrosugars, acids, aldehydes, furans and phenols, with yields of up to 500 L of bio-oil per dry ton of biomass (Brown, 2007) . The anhydrosguar levoglucosan (1,6-anhydro-β-d-glucopyranose) is the most abundant sugar in bio-oil and is thus the most attractive fermentation substrate. Pyrolysis of untreated biomass can produce bio-oil that contains up to 12% levoglucosan (Patwardhan et al., 2009; Patwardhan et al., 2010) ; pre-treatment of the biomass to remove cations can result in biooil that contains up to 30% levoglucosan (Piskorz, 1997) .
While levoglucosan can be converted to glucose by hydrolysis (Yu and Zhang, 2004) and then used as a fermentative substrate (Chan and Duff, 2010) , it is desirable to use biocatalysts that can directly metabolize bio-oil into biorenewable chemicals with minimal processing steps.
The feasibility of this approach was previously demonstrated using fungal biocatalysts (Prosen et NOTICE: This is the author's version of a work that was accepted for publication in Bioresource Technology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Bioresource Technology, 102 (17) al., 1993). However, our traditional workhorse biocatalysts, such as Escherichia coli, lack the inherent ability to metabolize this compound.
Levoglucosan is naturally abundant where forest fires or other types of biomass burning incidents have occurred. Several microorganisms have been identified that can use levoglucosan as carbon and energy source (Nakagawa et al., 1984; Prosen et al., 1993; Zhuang and Zhang, 2002) . For example, Aspergillus terreus K26 and Aspergillus niger CBX 209 can metabolize levoglucosan to produce itaconic acid (Nakagawa et al., 1984) and citric acid (Zhuang and Zhang, 2002) , respectively. Biochemical studies have shown that the Mg-ATP-dependent levoglucosan kinase (LGK) enzyme converts levoglucosan into glucose-6-phosphate (Kitamura et al., 1991) , routing it into the general glycolytic pathway. Given the status of E. coli as a premier industrial workhorse and producer of biorenewable chemicals, previous attempts have been made to engineer E. coli for levoglucosan utilization. The fungal LGK was cloned into E. coli from A. niger CBX-209, but the resulting enzyme activity was low (Zhuang and Zhang, 2002) . A more recent study isolated LGK from the yeast Lipomyces starkeyi YZ-215 and expressed it in E. coli; the resulting strain utilized levoglucosan as sole carbon source in minimal media (Dai et al., 2009) . Here, codon-optimized L. starkeyi LGK is expressed in ethanologenic E. coli KO11 (Ohta et al., 1991) and it is demonstrated that the engineered biocatalyst can utilize levoglucosan as a sole carbon and energy source and for ethanol production (Figure 1 ).
MATERIALS AND METHODS

Strains and media:
Ethanologenic E. coli KO11, a derivative of E. coli W engineered for ethanol production (Jarboe et al., 2007; Ohta et al., 1991) , was obtained from American Tissue NOTICE: This is the author's version of a work that was accepted for publication in Bioresource Technology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Bioresource Technology, 102 (17)2011,doi: 10.1016/j.biortech.2011.06.011.
Type Collection (ATCC, strain 55124). Chloramphenicol was used when KO11 was maintained on LB plates. Levoglucosan (1,6-anhydro-β-d-glucose) was obtained from Sigma. MOPS minimal media was made according to (Wanner, 1994) .
Genomic Integration of LGK: The L. starkeyi LGK sequence (GeneBank Accession # EU751287) was codon optimized for E. coli (Table 1) and synthesized by GenScript (Piscataway, New Jersey). The optimized sequence was amplified from its pUC57 construct for genomic integration by PCR using Taq DNA polymerase (Qiagen), with integration and verification primers as listed in Table 2 . Two integration sites within the pyruvate to ethanol (PET) genomic operon were utilized. Primer design for genomic integration was based on original reports of strain construction and our own sequence analysis (data not shown). Genomic integration was performed using the helper plasmid pKD46 (Datsenko and Wanner, 2000) , with successful integrants selected on MOPS minimal media with 0.5wt% levoglucosan and verified by PCR.
Growth Conditions:
For small-small analysis, cells were grown in 3mL cultures in 5 mL standing tubes with horizontal shaking at 80rpm for 24 or 48 hours. Cultures were inoculated to an initial OD550 of 0.05 in MOPS media with filter-sterilized glucose or levoglucosan.
Fermentations were performed at 37 0 C in 500mL fermentors in 350mL of Luria Broth (LB) with filter-sterilized glucose or levoglucosan. Fermentations were maintained at pH 6.5 by addition of 2N KOH, with stirring at 150rpm. Three biological replicates for each for levoglucosan and glucose were seeded at OD550 of 0.05 from a single culture grown in LB with no sugar. software for analysis. Samples were analyzed at 40 0 C in 8 mM sulfuric acid at a flowrate of 0.6 mL/min.
RESULTS AND DISCUSSION
E. coli KO11 lacks the inherent ability to metabolize levoglucosan, as evidenced by its inability to use levoglucosan as sole carbon source (Figure 2A) . The goal of this project was to engineer ethanologenic E. coli for levoglucosan utilization, and thus a LGK enzyme was needed in order to provide a pathway for levoglucosan utilization. The LGK gene from L. starkeyi YZ-215 was selected, given the previous success of this gene in E. coli (Dai et al., 2009 ). However, in this work the gene was codon-optimized for E. coli, increasing the codon adaptation index from 0.66 to 0.93. Codon optimization was performed by GenScript; the optimized sequence is given in Table 1 .
The pyruvate to ethanol (PET) operon was selected as our genomic integration site, since these genes are expressed at a level sufficient to enable redox balanced production of ethanol as the major fermentation product. The genomic integration strategy was such that the codonoptimized LGK gene was genomically integrated into the PET operon either between pyruvate decarboxylase (PDC) and alcohol dehydrogenase (ADH) (region 1) or between ADH and the existing chloramphenicol resistance (Cm R ) gene (region 2). Construction of the PET operon using Zymomonas mobilis genes and its genomic integration within E. coli were previously described (Ohta et al., 1991) .
Expression of the codon-optimized LGK gene in strain KO11 within either region 1 or region 2 enabled the use of levoglucosan as sole carbon source ( Figure 2B, 2C) , with trends and NOTICE: This is the author's version of a work that was accepted for publication in Bioresource Technology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Bioresource Technology, 102 (17) biomass yields comparable to the preferred carbon source glucose. These results confirm the ability of ethanologenic E. coli to use levoglucosan as sole carbon source for growth upon expression of LGK. The strain with the region 1 integration showed a slightly higher biomass accumulation on both glucose and levoglucosan and was used for all other experiments.
As the primary interest in levoglucosan utilization is for the production of biorenewable fuels and chemicals, such as ethanol, the fermentative performance of the engineered strain relative to the preferred carbon source glucose was characterized. Fermentations with pH-, temperature-and stir-controlled fermentations were performed for KO11 + lgkregion1. Given KO11's history of incomplete fermentations in minimal media (Jarboe et al., 2007) , rich media was used for these fermentations. As shown in Figure 3 , the engineered KO11 strain ferments levoglucosan to ethanol, though at a decreased titer (0.6 wt%) relative to the preferred carbon source glucose (0.8 wt%). The yields at 48 hours were 0.43 g ethanol produced per g glucose consumed and 0.35 g ethanol produced per g levoglucosan consumed.
The lower product titer can possibly be attributed to incomplete levoglucosan utilization: approximately 0.25wt% (15mM) levoglucosan remained after 48 hours. This incomplete levoglucosan utilization can in turn be possibly attributed to the relatively high substrate Km (71.2mM) of the LGK enzyme (Zhuang and Zhang, 2002) . It is also possible that levoglucosan utilization is transport-limited; the transporter responsible for levoglucosan uptake by E. coli is not known at this time.
CONCLUSIONS
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